# Hubei Xunda Pharmaceutical Co., Ltd. – FDA Inspection, May 26, 2017

Source: https://www.keypedia.com/records/fda_inspections/hubei-xunda-pharmaceutical-co-ltd/e9387c4f-30e0-4170-a983-42d3ad8e3504
Source feed: FDA_Inspections

> FDA inspection 1015952 of Hubei Xunda Pharmaceutical Co., Ltd., May 26, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1015952
- Company Name: Hubei Xunda Pharmaceutical Co., Ltd.
- Inspection Date: 2017-05-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)

Company: https://www.keypedia.com/companies/hubei-xunda-pharmaceutical-co-ltd/2beaa563-e464-473d-8ec1-7a46c02cfc23

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c